Medico Remedies
37.81
-0.51(-1.33%)
Market Cap₹313.76 Cr
PE Ratio27.41
IndustryHealthcare
Company Performance:
1D-1.33%
1M-15.09%
6M-21.69%
1Y-29.06%
5Y+56.24%
View Company Insightsright
More news about Medico Remedies
24Sept 25
Medico Remedies Wins Legal Battle: Bombay High Court Quashes Rs 2.94 Crore GST Demand
Medico Remedies Limited secured a significant legal victory as the Bombay High Court quashed show cause notices issued by the GST Authority, nullifying a GST demand of Rs 2.94 crore for FY 2017-18, 2018-19, and 2019-20. The court's decision eliminates the potential financial burden on the company. Medico Remedies acknowledged a delay in disclosing the initial show cause notice and committed to ensuring timely disclosures in the future. The company made this disclosure in compliance with SEBI Listing Regulations.
 no imag found
30Jul 25
Medico Remedies Announces Major Leadership Changes and Board Reshuffle
Medico Remedies Limited has made significant changes to its leadership structure. Mr. Harshit Mehta has been re-appointed as Managing Director for three years. Mr. Haresh Mehta will continue as Chairman & Whole-Time Director. Mr. Maheshkumar Darji joins as Additional Executive Director. Ms. Shreya Shah replaces Mr. Haresh Sanghvi as Secretarial Auditor. These changes are subject to shareholder approval at the upcoming 31st Annual General Meeting.
 no imag found
15May 25
Medico Remedies Invests Rs 30 Crore in New B-Lactam Formulations Factory
Medico Remedies Ltd has begun construction on a new Rs 30 crore factory for B-Lactam formulations. The facility is expected to increase annual revenue by Rs 25 crore upon completion and regulatory approval. This expansion aims to enhance production capacity, strengthen market position, and meet growing demand for essential antibiotics.
 no imag found
08Apr 25
Medico Remedies Secures $1.9 Million Supply Order from Dominican Republic
Medico Remedies Limited has won a government supply order worth $1.9 million (₹16.32 crore) from PROMESE/CAL in the Dominican Republic. The order includes tablets, capsules, and dry syrups to be delivered within three months. This international contract marks significant expansion for the company, demonstrating its ability to meet global quality standards and fulfill large-scale orders efficiently.
 no imag found
Medico Remedies
37.81
-0.51
(-1.33%)
1 Year Returns:-29.06%
Industry Peers
Sun Pharmaceutical
1,693.60
(-2.02%)
Divis Laboratories
5,856.50
(-0.85%)
Torrent Pharmaceuticals
3,987.20
(-3.02%)
Lupin
2,274.50
(-0.02%)
Dr Reddys Laboratories
1,217.30
(+0.64%)
Cipla
1,192.40
(-0.29%)
Zydus Life Science
864.25
(+0.12%)
Mankind Pharma
1,998.50
(-0.14%)
Aurobindo Pharma
1,333.70
(-0.63%)
Alkem Laboratories
5,258.00
(+0.26%)